Prelude Capital Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-52,467
| Closed | -$1.27M | – | 1325 |
|
|
2025
Q1 | $1.27M | Sell |
52,467
-1,299
| -2% | -$31.4K | 0.1% | 205 |
|
|
2024
Q4 | $2.16M | Buy |
+53,766
| New | +$2.16M | 0.14% | 142 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1418 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 1427 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1876 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1725 |
|
|
2019
Q3 | – | Sell |
-23,328
| Closed | -$194K | – | 1597 |
|
|
2019
Q2 | $194K | Sell |
23,328
-32,578
| -58% | -$271K | 0.01% | 472 |
|
|
2019
Q1 | $556K | Buy |
55,906
+24,872
| +80% | +$247K | 0.03% | 267 |
|
|
2018
Q4 | $237K | Buy |
31,034
+29,394
| +1,792% | +$224K | 0.02% | 460 |
|
|
2018
Q3 | $29K | Sell |
1,640
-77,872
| -98% | -$1.38M | ﹤0.01% | 912 |
|
|
2018
Q2 | $755K | Buy |
+79,512
| New | +$755K | 0.05% | 301 |
|